NCT04564365 is a clinical trial of beta-blocker in Acute Coronary Syndrome, sponsored by Chongqing Medical University.

Who is sponsoring NCT04564365?

NCT04564365 is sponsored by Chongqing Medical University.

What drugs are being tested in NCT04564365?

Interventions in NCT04564365: beta-blocker.

What condition does NCT04564365 study?

NCT04564365 studies Acute Coronary Syndrome.

Is NCT04564365 still recruiting?

NCT04564365 is currently status unknown. Last updated 11 November 2021.

Last reviewed 2021-11-11 · How we verify

NCT04564365

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction

Status unknown Last updated 11 November 2021

What this trial tests

trial testing beta-blocker in Acute Coronary Syndrome in 1,000 participants. Status unknown.

Timeline

30 June 2019

Primary endpoint
25 November 2021

25 December 2021

Quick facts

Lead sponsor	Chongqing Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	30 June 2019
Primary completion	25 November 2021
Estimated completion	25 December 2021
Sites	1 location across China

Drugs / interventions tested

beta-blocker

Conditions studied

Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →

Sponsor

Chongqing Medical University

Who can join

Adults 18 to 100, any sex, with Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of beta blockers after acute myocardial infarction is a core component of drug therapy, but evidence is primarily derived from patients who did not receive reperfusion therapy and secondary prophylaxis.In contemporary times, the prognostic value of beta blockers in patients with acute myocardial infarction has been questioned, particularly in patients without reduced heart failure/ejection fraction after acute myocardial infarction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
Wen XS, Luo R, Liu J, Liu ZQ, et al · · 2022 · cited 4× · PMID 35246866 · DOI 10.1002/clc.23807

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting

Other Chongqing Medical University trials

Trials by the same sponsor.

NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
NCT07503509 — Physiological Study of High PEEP in Noninvasive Ventilation · NA · recruiting
NCT06118671 — The Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients in Community · NA · unknown
NCT06272032 — Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis · EARLY_PHASE1 · unknown
NCT05974566 — Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04564365 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chongqing Medical University
Last refreshed: 11 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04564365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing